Gilles Berger

8PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid state chemistryTransition metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 13, 2026
Recent Advances in the Use of Osmium Complexes as Anticancer Phototherapeutics.

|Aug 07, 2023
An anti-glioblastoma gold(i)-NHC complex distorts mitochondrial morphology and bioenergetics to induce tumor growth inhibition.

Charles E Greif, R Tyler Mertens, Gilles Berger

|Jul 05, 2022
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.

Gilles Berger, Erik H Knelson, Jorge L Jimenez-Macias

|May 03, 2022
Surprising Chemistry of 6-Azidotetrazolo[5,1-a]phthalazine: What a Purported Natural Product Reveals about the Polymorphism of Explosives.

Aaron Gabriel Nunez Avila, Benoît Deschênes-Simard, Joseph E Arnold

|Apr 19, 2021
Reduction Mechanisms of Anticancer Osmium(VI) Complexes Revealed by Atomic Telemetry and Theoretical Calculations.

Gilles Berger, Anna Wach, Jacinto Sá

|Mar 06, 2020
Design and Synthesis of Backbone-Fused, Conformationally Constrained Morpholine-Proline Chimeras.

Sofiane Hocine, Gilles Berger, Stephen Hanessian

Pageof 2

Frequent Collaborators

2 joint publications

Stephen Hanessian

1 joint publications

Anna Wach

1 joint publications

Jacinto Sá

1 joint publications

Jakub Szlachetko